EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 105 filers reported holding EPIZYME INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $256,000 | -4.5% | 30,859 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $268,000 | -20.0% | 30,859 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $335,000 | -9.0% | 30,859 | 0.0% | 0.00% | -50.0% |
Q3 2020 | $368,000 | -30.4% | 30,859 | -6.4% | 0.00% | 0.0% |
Q2 2020 | $529,000 | +37.8% | 32,959 | +7.7% | 0.00% | 0.0% |
Q2 2019 | $384,000 | +140.0% | 30,614 | +135.7% | 0.00% | +100.0% |
Q1 2019 | $160,000 | +100.0% | 12,991 | 0.0% | 0.00% | – |
Q4 2018 | $80,000 | -41.6% | 12,991 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $137,000 | -22.2% | 12,991 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $176,000 | -23.5% | 12,991 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $230,000 | -43.2% | 12,991 | -59.8% | 0.00% | -50.0% |
Q4 2017 | $405,000 | -34.1% | 32,291 | 0.0% | 0.00% | -33.3% |
Q3 2017 | $615,000 | +26.3% | 32,291 | 0.0% | 0.00% | +50.0% |
Q2 2017 | $487,000 | +119.4% | 32,291 | +148.6% | 0.00% | +100.0% |
Q1 2017 | $222,000 | +41.4% | 12,991 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $157,000 | +23.6% | 12,991 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $127,000 | -4.5% | 12,991 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $133,000 | -15.3% | 12,991 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $157,000 | -24.5% | 12,991 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $208,000 | +24.6% | 12,991 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $167,000 | -46.3% | 12,991 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $311,000 | +28.0% | 12,991 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $243,000 | -0.8% | 12,991 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $245,000 | -65.2% | 12,991 | -50.0% | 0.00% | -50.0% |
Q3 2014 | $704,000 | – | 25,982 | – | 0.00% | – |
Q1 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2013 | $202,000 | +4.7% | 9,700 | +102.1% | 0.00% | 0.0% |
Q3 2013 | $193,000 | +144.3% | 4,800 | +71.4% | 0.00% | – |
Q2 2013 | $79,000 | – | 2,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
BP PLC | 24,687 | $28,000 | 0.16% |
NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |